MedTrace Logo

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

NCT03601221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1447

Last updated 2020-03-31

No results posted yet for this study

Summary

This is a HEV seroprevalence in the health donors in the Canton Ticino study. The pre-donation sampling pouch of each blood donor coming form the Cantone Ticino region will be collected and tested for HEV serology (IgM and IgG).

Conditions

  • Hepatitis E

Interventions

OTHER

Sample collection

Collection of one sampling pouch from each blood donor

Sponsors & Collaborators

  • Swiss Transfusion SRC

    collaborator OTHER

  • Clinical Trial Unit Ente Ospedaliero Cantonale

    collaborator OTHER

  • Ente Ospedaliero Cantonale, Bellinzona

    lead OTHER

Principal Investigators

  • Florian Bihl, MD · Ente Ospedaliero Cantonale, Bellinzona

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-29
Primary Completion
2018-12-31
Completion
2019-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03601221 on ClinicalTrials.gov